Text Size
5 studies found for:    weill | Open Studies | "Hepatitis, Chronic"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Open-Label Study of GS-7977+ Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Condition: Chronic Hepatitis C
Interventions: Drug: GS-7977 in combination with ribavirin;   Drug: GS-7977 400mg QD+ RBV BID+ PEG
2 Recruiting A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Conditions: Hepatitis B;   HBV
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620;   Drug: Multiple Ascending Dose (MAD) Cohorts
3 Recruiting A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Interventions: Drug: Single Ascending Dose (SAD) Cohorts GS-9620;   Drug: Multiple Ascending Dose (MAD) Cohorts GS-9620
4 Recruiting Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Condition: Hepatitis B Virus
Interventions: Drug: pegIFN;   Drug: pegIFNα-2a;   Drug: PegIFN lambda;   Drug: Entecavir
5 Recruiting Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Condition: Hepatitis C Virus
Interventions: Drug: Asunaprevir (ASV);   Drug: Daclatasvir (DCV);   Drug: PBO matching ASV;   Drug: Placebo (PBO) matching DCV;   Drug: Pegylated-interferon alfa 2a (PegIFN);   Drug: Ribavirin (RBV)
To Top

† Indicates status has not been verified in more than two years